Skip to main content

Table 5 Fractional shortening in both groups

From: Myocardial protection with histidine-tryptophan-ketoglutarate solution in comparison with hypothermic hyperkalemic blood solution in the correction of acyanotic congenital heart diseases

 

Group

P*

HTK

HHB

Mean

±SD

Median

IQR

Mean

±SD

Median

IQR

Preoperative FS%

30.17

2.02

30.00

29.00

32.00

31.33

5.25

30.00

28.00

32.00

0.263

Postoperative FS% (post CPB) at 0 h

30.20

2.22

30.00

28.00

32.00

32.20

8.27

32.00

28.00

32.00

0.206

Postoperative FS% at 24 h

29.20

2.04

29.00

27.00

32.00

29.20

7.12

29.00

27.00

32.00

1.0

Postoperative FS% at 48 h

29.37

2.27

30.00

28.00

32.00

30.40

4.09

30.00

28.00

32.00

0.231

  1. FS fractional shortening, CPB cardiopulmonary bypass, HTK histidine-tryptophan-ketoglutarate, HHB hypothermic hyperkalemic blood, SD standard deviation, IQR interquartile range; *Student’s t test
  2. P value < 0.05 was considered significant